Access to melanoma drugs in Spain: a cross-sectional survey.
Maria Gonzales CaoTeresa PuertolasJose Luis ManzanoCayetana MaldonadoOriol YelamosMiguel Ángel Berciano-GuerreroPablo CerezuelaJuan Martin-LiberalEva Muñoz-CouseloEnrique EspinosaAna DrozdowskyjAlfonso BerrocalAinara SoriaIvan Marquez-RodasSalvador Martin-AlgarraMaria QuindosSusana Puignull nullPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
For most indications that reimbursement is restricted out of the EMA indication, a great diversity on access was found throughout the different hospitals in Spain, including heterogeneity intra-AACC.
Keyphrases